Aspiriant LLC’s VF Corp VFC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,422
Closed -$211K 230
2019
Q2
$211K Sell
2,422
-627
-21% -$54K 0.02% 218
2019
Q1
$249K Sell
3,049
-788
-21% -$61.5K 0.02% 202
2018
Q4
$259K Sell
3,837
-563
-13% -$43.1K 0.02% 198
2018
Q3
$384K Sell
4,400
-259
-6% -$22.1K 0.03% 175
2018
Q2
$358K Sell
4,659
-563
-11% -$42.4K 0.03% 188
2018
Q1
$364K Buy
+5,222
New +$378K 0.03% 172
2017
Q4
Sell
-6,606
Closed -$395K 179
2017
Q3
$395K Sell
6,606
-3,533
-35% -$204K 0.03% 148
2017
Q2
$550K Sell
10,139
-1,482
-13% -$76.5K 0.05% 139
2017
Q1
$602K Sell
11,621
-818
-7% -$40.4K 0.05% 141
2016
Q4
$625K Sell
12,439
-1,646
-12% -$85.4K 0.06% 127
2016
Q3
$743K Buy
+14,085
New +$813K 0.07% 118

Other funds holding VFC

Aspiriant LLC's VFC Position: Q3 2019 in Review

Aspiriant LLC sold out of VF Corp (VFC) in Q3 2019, closing a stake of 2,422 shares — an estimated $211K sold.

Aspiriant LLC first reported a position in VFC in Q3 2016 and held it in 11 quarters. The position peaked at $743K in Q3 2016. 943 funds tracked by Wall St. Rank hold VFC as of Q3 2019.

  • Aspiriant LLC reported no remaining VF Corp position as of Q3 2019 after selling out during the quarter.
  • Aspiriant LLC sold 2,422 VF Corp shares in Q3 2019, an estimated $211K.
  • Aspiriant LLC first reported a position in VF Corp in Q3 2016 and held it in 11 quarters.
  • Aspiriant LLC's VF Corp position peaked at $743K in Q3 2016.
  • 943 funds tracked by Wall St. Rank held VF Corp as of Q3 2019.

Based on Aspiriant LLC's 13F filing for Q3 2019, filed 4 Nov 2019.